Welcome to our dedicated page for Trupanion news (Ticker: TRUP), a resource for investors and traders seeking the latest updates and insights on Trupanion stock.
Trupanion Inc. (TRUP) delivers innovative medical insurance for pets through its subscription-based model and patented direct payment technology. This dedicated news hub provides investors and industry professionals with essential updates on the company’s financial performance, strategic partnerships, and operational developments.
Access real-time information about earnings reports, management changes, and technology advancements that shape TRUP’s position in the growing $4 billion pet insurance market. Our curated collection includes press releases on veterinary network expansions, product enhancements, and data-driven initiatives that demonstrate Trupanion’s leadership in claims processing efficiency.
Key updates cover both business segments: consumer-focused subscription growth and B2B software solutions for veterinary practices. Bookmark this page to monitor how TRUP addresses rising pet healthcare costs through its unique real-time payment system and actuarial expertise developed over 20+ years.
Trupanion, Inc. (TRUP) will participate virtually in the Canaccord Genuity 41st Annual Growth Conference on August 12, 2021. Co-President Tricia Plouf is scheduled to present at 3:00 pm ET and engage in meetings with investors. The event will be web broadcasted and accessible via Trupanion's Investor Relations website. Founded in 2000 and headquartered in Seattle, Trupanion specializes in medical insurance for pets in the U.S. and Canada, offering unlimited payouts for the life of the pets.
Trupanion, a leading provider of medical insurance for pets, reported strong Q2 2021 results, showcasing a 43% revenue increase to $168.3 million year-over-year. Total enrolled pets reached over 1 million, a 38% rise from Q2 2020. Subscription revenue also grew by 30%, totaling $120.4 million. However, the company faced a net loss of $9.2 million, compared to a net income of $1.4 million in the same quarter last year, largely driven by increased acquisition spending and stock-based compensation. Adjusted EBITDA dropped to $0.2 million from $5.5 million in Q2 2020.
Trupanion, a leader in medical insurance for pets, will release its financial results for Q2 2021 on August 5, 2021, after market close. A conference call will take place at 1:30 PM PT / 4:30 PM ET to discuss these results. Investors can access the call via phone or a live webcast on Trupanion's Investor Relations site, where an archived version of the call will be available for three months. Founded in 2000 and headquartered in Seattle, Trupanion aims to provide high-value pet medical insurance with unlimited payouts for pet owners.
Trupanion (NASDAQ: TRUP) announced its upcoming participation in the BofA Securities 2021 InsurTech Conference on June 30, 2021. Co-President Tricia Plouf will present virtually at 4:15 pm ET, and the presentation will be available via webcast on Trupanion’s Investor Relations website. Trupanion has over two decades of experience in providing medical insurance for pets in the U.S. and Canada, focusing on high-value coverage with unlimited payouts for pet owners.
Trupanion launched TruCuddle on Veterinary Appreciation Day (June 18) to support veterinary professionals. This initiative addresses burnout and emotional stress within the field, contributing to grants and educational programs. Trupanion will donate $250 to organizations like Not One More Vet and Multicultural Veterinary Medical Association for each download of its payment solution software. Additionally, Trupanion committed over $4.9 million in stock to the MightyVet initiative, promoting veterinary well-being. The campaign runs until October 23, 2021.
Trupanion has appointed Simon Wheeler as Executive Vice President of International Business, emphasizing its strategy for global expansion in the pet insurance market. With over 30 years of experience, Wheeler aims to double the company’s addressable market by 2035 and drive growth in key international markets, including Japan, the UK, Brazil, and Western Europe. Notably, Trupanion's recent alliance with Aflac presents significant opportunities for entering the Japanese market, where Aflac has a strong customer base.
Trupanion announced a significant donation to support the veterinary industry, committing to issue over 50,000 shares of stock worth over $4.7 million to MightyVet. This donation precedes Veterinary Appreciation Day on June 18, 2021, recognizing the dedication of veterinary professionals during challenging times like the pandemic. Trupanion emphasizes the importance of supporting these unsung heroes in providing care for pets.
Trupanion, a leader in pet medical insurance, will host its 2021 Annual Meeting of Stockholders on June 16, 2021, at its Seattle headquarters. The meeting, starting at 9 am PT, will be followed by an informational session featuring extensive Q&A regarding the company’s 60-month plan. Participation is available in-person or via an online webinar, requiring pre-registration. Stockholders are encouraged to vote in advance to ensure their shares are represented. Trupanion is dedicated to providing high-value insurance with unlimited payouts for pet medical needs.
Trupanion (Nasdaq: TRUP) has announced participation in two upcoming virtual investor conferences: the Stifel 2021 Virtual Jaws & Paws Conference on June 3, 2021, and the Evercore ISI Inaugural TMT Conference on June 8, 2021. Co-Presidents Tricia Plouf and Margi Tooth will present on June 3 at 12:30 p.m. ET, followed by CEO Darryl Rawlings on June 8 at 11:00 a.m. ET. Presentations will be available via webcast on Trupanion's Investor Relations website.
Trupanion, a leader in medical insurance for pets, will hold its Annual Meeting of Stockholders on June 16, 2021, at 9:00 am Pacific Time at its Seattle headquarters. Stockholders as of April 20, 2021, can vote during the meeting, with a preference for online, mail, or telephone voting. The event will feature a formal meeting followed by an extended informational session for shareholders to engage with management. Limited in-person attendance is available with required COVID-19 testing. A live webinar will also be offered for remote participation.